{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:09:35Z","timestamp":1792030175148,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004505","name":"Universit\u00e0 degli Studi di Catania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Schizophrenia and bipolar disorder significantly impair daily functioning and quality of life. Effective treatment monitoring requires tools assessing both clinical symptoms and everyday impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This cross-sectional study explored relationships between symptoms, side effects, and functioning using clinician-rated and patient-reported measures. We examined whether the Glasgow Antipsychotic Side-Effect Scale (GASS), a patient-reported outcome measure (PROM), is associated with disability and quality of life comparably to the clinician-administered Udvalg for Kliniske Unders\u00f8gelser (UKU) Side Effect Rating Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We recruited 100 individuals with schizophrenia spectrum or bipolar disorders receiving antipsychotic treatment. Linear regressions and network analyses were conducted. Linear regressions assessed the association between side effects, disability (World Health Organization Disability Assessment Schedule, WHODAS) and quality of life (EuroQol 5-Dimension scale, EQ-5D). Network analyses were conducted to explore the interplay between side effects, disability, quality of life and symptoms, the latter assessed using the Positive and Negative Syndrome Scale (PANSS), Young Mania Rating Scale (YMRS), and Montgomery\u2013\u00c5sberg Depression Rating Scale (MADRS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Side effects assessed with GASS and UKU significantly impacted disability (GASS:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001, 95% CI [0.274; 0.635]; UKU:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001, 95% CI [0.313; 1.021]) and reduced quality of life (GASS:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001, 95% CI [-1.391; -0.511]; UKU:\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001, 95% CI [-3.176; -1.668]). Network analysis identified depressive symptoms as central in the UKU network and autonomic side effects as central in the GASS network.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GASS total and subgroup scores showed comparable associations with disability and quality of life as UKU. Integrating both perspectives enables comprehensive monitoring and patient-centred care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00406-025-02169-8","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T04:27:35Z","timestamp":1765772855000},"page":"2861-2869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quality of life, disability and antipsychotics-related side effects in schizophrenia spectrum and bipolar disorder: the role of patient-reported outcome measures"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4923-9301","authenticated-orcid":false,"given":"Sofia Francesca","family":"Aprile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2196-0601","authenticated-orcid":false,"given":"Alessandro","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5470-142X","authenticated-orcid":false,"given":"Sabrina","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfelice","family":"Cutrufelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Francesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4934-4352","authenticated-orcid":false,"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-6054","authenticated-orcid":false,"given":"Filippo","family":"Caraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6926-0762","authenticated-orcid":false,"given":"Andrea","family":"Fiorillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5835-4176","authenticated-orcid":false,"given":"Maria Salvina","family":"Signorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2169_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1056\/NEJMra1801490","volume":"379","author":"JA Lieberman","year":"2018","unstructured":"Lieberman JA, First MB (2018) Psychotic disorders. N Engl J Med 379:270\u2013280. https:\/\/doi.org\/10.1056\/NEJMra1801490","journal-title":"N Engl J Med"},{"key":"2169_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40261-024-01391-x","volume":"44","author":"A Rodolico","year":"2024","unstructured":"Rodolico A, Aprile SF, Cutrufelli P, Privitera G, Castellano S, Concerto C, Furnari R, Guerrera CS, Mineo L, Platania GA, Petralia A, Caraci F, Signorelli MS (2024) Disability and adverse effects of oral versus long-acting injectable antipsychotics in schizophrenia-spectrum and bipolar disorder: a comparison based on data-driven taxonomy. Clin Drug Investig 44:715\u2013727. https:\/\/doi.org\/10.1007\/s40261-024-01391-x","journal-title":"Clin Drug Investig"},{"key":"2169_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health","year":"2006","unstructured":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79. https:\/\/doi.org\/10.1186\/1477-7525-4-79","journal-title":"Health Qual Life Outcomes"},{"key":"2169_CR4","doi-asserted-by":"publisher","first-page":"f167","DOI":"10.1136\/bmj.f167","volume":"346","author":"N Black","year":"2013","unstructured":"Black N (2013) Patient reported outcome measures could help transform healthcare. BMJ 346:f167. https:\/\/doi.org\/10.1136\/bmj.f167","journal-title":"BMJ"},{"key":"2169_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-024-00804-x","volume":"9","author":"L San","year":"2025","unstructured":"San L, Arranz B, Romans C, Garc\u00eda B, Coromina M, Ortiz S, Vilaplana M, Soto V, Villaescusa R, Alvaros J (2025) Patient-reported outcome measures to assess mental and physical health status, functionality, and quality of life in patients with major depression or schizophrenia. J Patient-Rep Outcomes 9:4. https:\/\/doi.org\/10.1186\/s41687-024-00804-x","journal-title":"J Patient-Rep Outcomes"},{"key":"2169_CR6","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1302\/0301-620X.93B7.25737","volume":"93","author":"O Rolfson","year":"2011","unstructured":"Rolfson O, K\u00e4rrholm J, Dahlberg LE, Garellick G (2011) Patient-reported outcomes in the Swedish hip arthroplasty register: results of a nationwide prospective observational study. J Bone Joint Surg Br 93:867\u2013875. https:\/\/doi.org\/10.1302\/0301-620X.93B7.25737","journal-title":"J Bone Joint Surg Br"},{"key":"2169_CR7","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/1472-6963-13-211","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211. https:\/\/doi.org\/10.1186\/1472-6963-13-211","journal-title":"BMC Health Serv Res"},{"key":"2169_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.schres.2017.04.049","volume":"192","author":"E Shadmi","year":"2018","unstructured":"Shadmi E, Gelkopf M, Garber-Epstein P, Baloush-Kleinman V, Doudai R, Roe D (2018) Routine patient reported outcomes as predictors of psychiatric rehospitalization. Schizophr Res 192:119\u2013123. https:\/\/doi.org\/10.1016\/j.schres.2017.04.049","journal-title":"Schizophr Res"},{"key":"2169_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"334","author":"O Lingjaerde","year":"1987","unstructured":"Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334:1\u2013100. https:\/\/doi.org\/10.1111\/j.1600-0447.1987.tb10566.x","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"2169_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jpsychires.2021.12.053","volume":"147","author":"B Buck","year":"2022","unstructured":"Buck B, Gagen EC, Halverson TF, Nagendra A, Ludwig KA, Fortney JC (2022) A systematic search and critical review of studies evaluating psychometric properties of patient-reported outcome measures for schizophrenia. J Psychiatr Res 147:13\u201323. https:\/\/doi.org\/10.1016\/j.jpsychires.2021.12.053","journal-title":"J Psychiatr Res"},{"key":"2169_CR11","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1007\/s11136-017-1659-5","volume":"26","author":"A Obbarius","year":"2017","unstructured":"Obbarius A, van Maasakkers L, Baer L, Clark DM, Crocker AG, de Beurs E, Emmelkamp PMG, Furukawa TA, Hedman-Lagerl\u00f6f E, Kangas M, Langford L, Lesage A, Mwesigire DM, Nolte S, Patel V, Pilkonis PA, Pincus HA, Reis RA, Rojas G, Sherbourne C, Smithson D, Stowell C, Woolaway-Bickel K, Rose M (2017) Standardization of health outcomes assessment for depression and anxiety: recommendations from the ICHOM Depression and Anxiety Working Group. Qual Life Res 26:3211\u20133225. https:\/\/doi.org\/10.1007\/s11136-017-1659-5","journal-title":"Qual Life Res"},{"key":"2169_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0269881107087976","volume":"22","author":"L Waddell","year":"2008","unstructured":"Waddell L, Taylor M (2008) A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol Oxf Engl 22:238\u2013243. https:\/\/doi.org\/10.1177\/0269881107087976","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"2169_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/wps.20375","volume":"16","author":"D Borsboom","year":"2017","unstructured":"Borsboom D (2017) A network theory of mental disorders. World Psychiatry 16:5\u201313. https:\/\/doi.org\/10.1002\/wps.20375","journal-title":"World Psychiatry"},{"key":"2169_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/brainsci12070891","volume":"12","author":"A Rodolico","year":"2022","unstructured":"Rodolico A, Concerto C, Ciancio A, Siafis S, Fusar-Poli L, Romano CB, Scavo EV, Petralia A, Salomone S, Signorelli MS, Leucht S, Aguglia E (2022) Validation of the Glasgow antipsychotic Side-Effect scale (GASS) in an Italian sample of patients with stable schizophrenia and bipolar spectrum disorders. Brain Sci 12:891. https:\/\/doi.org\/10.3390\/brainsci12070891","journal-title":"Brain Sci"},{"key":"2169_CR15","volume-title":"Principles and practice of structural equation modeling","author":"RB Kline","year":"2011","unstructured":"Kline RB (2011) Principles and practice of structural equation modeling. Guilford Publications, New York"},{"key":"2169_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261\u2013276. https:\/\/doi.org\/10.1093\/schbul\/13.2.261","journal-title":"Schizophr Bull"},{"key":"2169_CR17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR (2005) Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162:441\u2013449. https:\/\/doi.org\/10.1176\/appi.ajp.162.3.441","journal-title":"Am J Psychiatry"},{"key":"2169_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry J Ment Sci 133:429\u2013435. https:\/\/doi.org\/10.1192\/bjp.133.5.429","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"2169_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry J Ment Sci 134:382\u2013389. https:\/\/doi.org\/10.1192\/bjp.134.4.382","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"2169_CR20","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/09638280802240498","volume":"31","author":"S Federici","year":"2009","unstructured":"Federici S, Meloni F, Mancini A, Lauriola M, Olivetti Belardinelli M (2009) World health organisation disability assessment schedule II: contribution to the Italian validation. Disabil Rehabil 31:553\u2013564. https:\/\/doi.org\/10.1080\/09638280802240498","journal-title":"Disabil Rehabil"},{"key":"2169_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group (1990) EuroQol\u2013a new facility for the measurement of health-related quality of life. Health Policy Amst Neth 16:199\u2013208. https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9","journal-title":"Health Policy Amst Neth"},{"key":"2169_CR22","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1177\/0269881115593893","volume":"29","author":"AM van Strien","year":"2015","unstructured":"van Strien AM, Keijsers CJ, Derijks HJ, van Marum RJ (2015) Rating scales to measure side effects of antipsychotic medication: a systematic review. J Psychopharmacol 29:857\u2013866. https:\/\/doi.org\/10.1177\/0269881115593893","journal-title":"J Psychopharmacol"},{"key":"2169_CR23","volume-title":"Introduction to linear regression analysis","author":"DC Montgomery","year":"2013","unstructured":"Montgomery DC, Peck EA, Vining GG (2013) Introduction to linear regression analysis. John Wiley & Sons, Hoboken"},{"key":"2169_CR24","volume-title":"Introduction to mediation, moderation, and conditional process analysis: a regression-based approach","author":"AF Hayes","year":"2013","unstructured":"Hayes AF (2013) Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. The Guilford Press, New York, NY, US"},{"key":"2169_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","volume":"1","author":"KJ Rothman","year":"1990","unstructured":"Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiol Camb Mass 1:43\u201346","journal-title":"Epidemiol Camb Mass"},{"key":"2169_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.2034","volume":"33","author":"G Briganti","year":"2024","unstructured":"Briganti G, Scutari M, Epskamp S, Borsboom D, Hoekstra RHA, Golino HF, Christensen AP, Morvan Y, Ebrahimi OV, Costantini G, Heeren A, de Ron J, Bringmann LF, Huth K, Haslbeck JMB, Isvoranu A, Marsman M, Blanken T, Gilbert A, Henry TR, Fried EI, McNally RJ (2024) Network analysis: an overview for mental health research. Int J Methods Psychiatr Res 33:e2034. https:\/\/doi.org\/10.1002\/mpr.2034","journal-title":"Int J Methods Psychiatr Res"},{"key":"2169_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1146\/annurev-clinpsy-050212-185608","volume":"9","author":"D Borsboom","year":"2013","unstructured":"Borsboom D, Cramer AOJ (2013) Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol 9:91\u2013121. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050212-185608","journal-title":"Annu Rev Clin Psychol"},{"key":"2169_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v048.i04","volume":"48","author":"S Epskamp","year":"2012","unstructured":"Epskamp S, Cramer AOJ, Waldorp LJ, Schmittmann VD, Borsboom D (2012) Qgraph: network visualizations of relationships in psychometric data. J Stat Softw 48:1\u201318. https:\/\/doi.org\/10.18637\/jss.v048.i04","journal-title":"J Stat Softw"},{"key":"2169_CR29","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/biostatistics\/kxm045","volume":"9","author":"J Friedman","year":"2008","unstructured":"Friedman J, Hastie T, Tibshirani R (2008) Sparse inverse covariance estimation with the graphical Lasso. Biostat Oxf Engl 9:432\u2013441. https:\/\/doi.org\/10.1093\/biostatistics\/kxm045","journal-title":"Biostat Oxf Engl"},{"key":"2169_CR30","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1037\/met0000167","volume":"23","author":"S Epskamp","year":"2018","unstructured":"Epskamp S, Fried EI (2018) A tutorial on regularized partial correlation networks. Psychol Methods 23:617\u2013634. https:\/\/doi.org\/10.1037\/met0000167","journal-title":"Psychol Methods"},{"key":"2169_CR31","unstructured":"Foygel R, Drton M (2010) Extended Bayesian information criteria for Gaussian graphical models"},{"key":"2169_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jrp.2014.07.003","author":"G Costantini","year":"2014","unstructured":"Costantini G, Epskamp S, Borsboom D, Perugini M, M\u00f5ttus R, Waldorp LJ, Cramer AOJ (2014) State of the aRt personality research: a tutorial on network analysis of personality data in R. J Res Personal. https:\/\/doi.org\/10.1016\/j.jrp.2014.07.003","journal-title":"J Res Personal"},{"key":"2169_CR33","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1037\/abn0000181","volume":"125","author":"DJ Robinaugh","year":"2016","unstructured":"Robinaugh DJ, Millner AJ, McNally RJ (2016) Identifying highly influential nodes in the complicated grief network. J Abnorm Psychol 125:747\u2013757. https:\/\/doi.org\/10.1037\/abn0000181","journal-title":"J Abnorm Psychol"},{"key":"2169_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/wps.21189","volume":"23","author":"P Fusar-Poli","year":"2024","unstructured":"Fusar-Poli P, Estrad\u00e9 A, Esposito CM, Rosfort R, Basadonne I, Mancini M, Stanghellini G, Otaiku J, Olanrele O, Allen L, Lamba M, Alaso C, Ieri J, Atieno M, Oluoch Y, Ireri P, Tembo E, Phiri IZ, Nkhoma D, Sichone N, Siadibbi C, Sundi PRIO, Ntokozo N, Fusar-Poli L, Floris V, Mensi MM, Borgatti R, Damiani S, Provenzani U, Brondino N, Bonoldi I, Radua J, Cooper K, Shin JI, Cortese S, Danese A, Bendall S, Arango C, Correll CU, Maj M (2024) The lived experience of mental disorders in adolescents: a bottom-up review co-designed, co-conducted and co-written by experts by experience and academics. World Psychiatry 23:191\u2013208. https:\/\/doi.org\/10.1002\/wps.21189","journal-title":"World Psychiatry"},{"key":"2169_CR35","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/wps.20959","volume":"21","author":"P Fusar-Poli","year":"2022","unstructured":"Fusar-Poli P, Estrad\u00e9 A, Stanghellini G, Venables J, Onwumere J, Messas G, Gilardi L, Nelson B, Patel V, Bonoldi I, Aragona M, Cabrera A, Rico J, Hoque A, Otaiku J, Hunter N, Tamelini MG, Maschi\u00e3o LF, Puchivailo MC, Piedade VL, K\u00e9ri P, Kpodo L, Sunkel C, Bao J, Shiers D, Kuipers E, Arango C, Maj M (2022) The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics. World Psychiatry 21:168\u2013188. https:\/\/doi.org\/10.1002\/wps.20959","journal-title":"World Psychiatry"},{"key":"2169_CR36","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.schres.2025.05.008","volume":"281","author":"SF Aprile","year":"2025","unstructured":"Aprile SF, Rodolico A, Di Francesco A, Cutrufelli P, Bighelli I, Castellano S, Signorelli MS, Leucht S, Caraci F (2025) Exploring weight gain and body image in schizophrenia spectrum disorders: a systematic review of qualitative studies. Schizophr Res 281:177\u2013179. https:\/\/doi.org\/10.1016\/j.schres.2025.05.008","journal-title":"Schizophr Res"},{"key":"2169_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2025.116460","volume":"348","author":"SF Aprile","year":"2025","unstructured":"Aprile SF, Rodolico A, Di Francesco A, Varrasi S, Bighelli I, Castellano S, Signorelli MS, Leucht S, Caraci F (2025) Oral versus long-acting injectable antipsychotics in schizophrenia spectrum disorders: a systematic review of patients\u2019 subjective experiences. Psychiatry Res 348:116460. https:\/\/doi.org\/10.1016\/j.psychres.2025.116460","journal-title":"Psychiatry Res"},{"key":"2169_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13111577","volume":"13","author":"G Sampogna","year":"2023","unstructured":"Sampogna G, Di Vincenzo M, Giuliani L, Menculini G, Mancuso E, Arsenio E, Cipolla S, Della Rocca B, Martiadis V, Signorelli MS, Fiorillo A (2023) A systematic review on the effectiveness of antipsychotic drugs on the quality of life of patients with schizophrenia. Brain Sci 13:1577. https:\/\/doi.org\/10.3390\/brainsci13111577","journal-title":"Brain Sci"},{"key":"2169_CR39","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s11136-020-02558-7","volume":"29","author":"L Liu","year":"2020","unstructured":"Liu L, Suo T, Shen Y, Geng C, Song Z, Liu F, Wang J, Xie Y, Zhang Y, Tang T, Zhang L, Wang W (2020) Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Qual Life Res Int J Qual Life Asp Treat Care Rehabil 29:3009\u20133015. https:\/\/doi.org\/10.1007\/s11136-020-02558-7","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"2169_CR40","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.1038\/srep05918","volume":"4","author":"CD van Borkulo","year":"2014","unstructured":"van Borkulo CD, Borsboom D, Epskamp S, Blanken TF, Boschloo L, Schoevers RA, Waldorp LJ (2014) A new method for constructing networks from binary data. Sci Rep 4:5918. https:\/\/doi.org\/10.1038\/srep05918","journal-title":"Sci Rep"},{"key":"2169_CR41","doi-asserted-by":"publisher","first-page":"309","DOI":"10.29399\/npa.28089","volume":"59","author":"HEA \u00c7elik","year":"2022","unstructured":"\u00c7elik HEA, Ceylan D, Ba\u011fc\u0131 B, Akdede BB, Alptekin K, \u00d6zerdem A (2022) Quality of life of individuals with bipolar disorder and schizophrenia. Noro Psikiyatri Ars 59:309\u2013314. https:\/\/doi.org\/10.29399\/npa.28089","journal-title":"Noro Psikiyatri Ars"},{"key":"2169_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/19585969.2025.2463443","volume":"27","author":"T Korchia","year":"2025","unstructured":"Korchia T, Faug\u00e8re M, Achour V, Maakaron E, Andrieu-Haller C, Fond G, Lan\u00e7on C (2025) Impact of perceived side-effects of psychotropic treatments on quality of life in patients with severe mental illness. Dialogues Clin Neurosci 27:10\u201319. https:\/\/doi.org\/10.1080\/19585969.2025.2463443","journal-title":"Dialogues Clin Neurosci"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02169-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-02169-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02169-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T16:01:59Z","timestamp":1788019319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-02169-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2169"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-02169-8","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human patients were approved by the Institutional Review Board of the University of Catania (Protocol number: 1521).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects provided written informed consent for their scores to be used for research purposes.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}